APP and Alzheimer disease: In the framework of the ACH2.0, potentially, as discussed in [4], AD could be prevented, or its progression could be ceased via long-term inhibition of the ISR, for example with the small molecule ISR inhibitor ISRIB; this would preclude or stop the operation of the AβPP-independent iAβ generation pathway and, consequently, of the AD Engine.